Collective Intelligence Systems

Uses the CrowdMeter app to study how shared crowd signals can influence individual decisions about crowding and public health risks, exploring behavioral dynamics in real-world settings.

Designs and researches human computation systems that integrate networked people and machines to address complex problems in health, education, and humanitarian contexts. This includes developing novel methods and platforms to enable large-scale collaborative problem-solving.

Runs multiple citizen science initiatives—such as Stall Catchers, Beta Catchers, and Dream Catchers—that engage the public in analyzing biomedical data to accelerate Alzheimer's and SIDS research, often in collaboration with academic laboratories.

Produces scholarly publications including the journal Human Computation, edited volumes, and books that explore foundational and applied aspects of human-machine collaboration across disciplines such as crisis response, scientific research, and digital curation.

Organizes and disseminates talks, seminars, newsletters, and event highlights to foster knowledge exchange and community engagement in the field of human computation.

Supports improved OpenStreetMap coverage in rural Tanzania through the Crowd2Map Tanzania initiative, contributing to local development, safety, and gender equity by enabling community-led mapping efforts.

Develops and operates Polymath Plus, an AI-assisted, interactive platform that enables collaborative work on mathematical proofs and research, supporting online cooperation between mathematicians and the public.

Hosts a forum for discussion on problems, treatments, and recent advancements related to velo-cardio-facial syndrome, craniofacial disorders, genetic syndromes, and their management.

Offers free consultation and information to families and clinicians about velo-cardio-facial syndrome, craniofacial disorders, and genetic syndromes, including updates on research and treatment outcomes.

Performs and publishes comparative analyses of susceptible breakpoints across international standards organizations (USA-FDA, CLSI, EUCAST-SC, USCAST) for key drug classes such as fluoroquinolones, aminoglycosides, oxazolidinones, and peptides to inform harmonization and best practices.

Makes updated susceptibility test interpretive criteria (STIC) tables and supporting materials widely accessible by publishing them online in searchable formats, including video presentations, slide decks, and public document repositories to ensure broad stakeholder access.

Develops and establishes scientifically rigorous standards for testing and interpreting the activity of antibacterial agents, in collaboration with global partners, to support antimicrobial stewardship and clinical decision-making.

Awards grants to support the general operations of Ronald McDonald House Charities of Madison, enabling its services for families of hospitalized children.

Conducts research to generate, update, and finalize in vitro susceptibility test interpretive criteria (STIC) for various antibiotic-pathogen combinations, including ceftriaxone, azithromycin, piperacillin-tazobactam, and minocycline, using pharmacometric and evidence-based approaches. Publishes annual editions (e.g., 2021, 2024, 2025) as downloadable, searchable PDFs with supporting rationale documents.

Produces and publishes detailed rationale and evaluation documents for specific antimicrobial agents, including oritavancin, tedizolid, dalbavancin, telavancin, aminoglycosides, fluoroquinolones, and polymyxins, with multiple versions released between 2016 and 2019 to support transparent and evidence-based breakpoint decisions.

Provides training and resources to educate radiologists on engaging in policy and legislative advocacy at federal and state levels.

Produces and publishes peer-reviewed research, white papers, and policy reports on radiology practice and health policy; co-authored summaries of national meetings and contributes to the ACR Bulletin, with research reaching broad audiences through media coverage.

Runs federal and state-level advocacy campaigns to influence radiology-related policies and regulations, including legislation on insurance coverage for image-guided breast biopsies and bans on non-compete clauses for medical professionals.